Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Am J Med
1 Arch Virol
2 BMC Pediatr
3 Cell
1 Epidemiol Infect
1 J Gen Virol
19 J Infect
18 J Infect Dis
1 J Virol
1 J Virol Methods
3 Lancet
9 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Pediatrics
4 PLoS Comput Biol
42 PLoS One
7 Proc Natl Acad Sci U S A
7 Vaccine

    Am J Med

  1. SIM JJL, Lim CC
    Influenza vaccination in Systemic Lupus Erythematosus: Efficacy, Effectiveness, Safety, Utilization and Barriers.
    Am J Med. 2021 Sep 23. pii: S0002-9343(21)00608.
    >> Share

    Arch Virol

  2. SUN Y, Mao H, Lou X, Wang X, et al
    Molecular epidemiologic characteristics of hemagglutinin from five waves of avian influenza A (H7N9) virus infection, from 2013 to 2017, in Zhejiang Province, China.
    Arch Virol. 2021 Sep 30. pii: 10.1007/s00705-021-05233.
    >> Share

    BMC Pediatr

  3. GUO X, Hua H, Xu J, Liu Z, et al
    Associations of childhood unintentional injuries with maternal emotional status during COVID-19.
    BMC Pediatr. 2021;21:422.
    >> Share

  4. HADIANFARD AM, Mozaffari-Khosravi H, Karandish M, Azhdari M, et al
    Physical activity and sedentary behaviors (screen time and homework) among overweight or obese adolescents: a cross-sectional observational study in Yazd, Iran.
    BMC Pediatr. 2021;21:421.
    >> Share


  5. MOON S, Agarwal S, Becker A, Alonso Ruiz A, et al
    Embedding global access in development of future pandemic vaccines.
    BMJ. 2021;374:n2256.
    >> Share

  6. SAXENA S, Skirrow H, Bedford H, Wighton K, et al
    Covid-19 vaccines for teenagers: conversations and consent.
    BMJ. 2021;374:n2312.
    >> Share

  7. SCOTT J, Richterman A, Cevik M
    Covid-19 vaccination: evidence of waning immunity is overstated.
    BMJ. 2021;374:n2320.
    >> Share

  8. SIEMIENIUK RA, Bartoszko JJ, Diaz Martinez JP, Kum E, et al
    Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
    BMJ. 2021;374:n2231.
    >> Share


  9. ZELLER M, Gangavarapu K, Anderson C, Smither AR, et al
    Emergence of an early SARS-CoV-2 epidemic in the United States.
    Cell. 2021;184:4939-4952.
    >> Share

  10. SPOSITO B, Broggi A, Pandolfi L, Crotta S, et al
    The interferon landscape along the respiratory tract impacts the severity of COVID-19.
    Cell. 2021;184:4953-4968.
    >> Share

  11. HOLMES EC, Goldstein SA, Rasmussen AL, Robertson DL, et al
    The origins of SARS-CoV-2: A critical review.
    Cell. 2021;184:4848-4856.
    >> Share

    Epidemiol Infect

  12. KEITA MB, Pierre F, Ndjomou J, Traore B, et al
    The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
    Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.
    >> Share

    J Gen Virol

  13. HUSSAIN S, Daniels RS, Wharton SA, Howell S, et al
    Reduced sialidase activity of influenza A(H3N2) neuraminidase associated with positively charged amino acid substitutions.
    J Gen Virol. 2021;102.
    >> Share

    J Infect

    Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
    >> Share

  15. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    >> Share

  16. LAI CK, Lui GC, Chen Z, Cheung YY, et al
    Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
    >> Share

  17. BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
    Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
    J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
    >> Share

  18. GAO S, Lu Y, Luan J, Zhang L, et al
    Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
    >> Share

  19. NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
    Cytomegalovirus infection in critically ill patients with COVID-19.
    J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
    >> Share

  20. ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
    Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
    J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
    >> Share

  21. GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
    Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
    >> Share

  22. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    >> Share

  23. WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
    Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
    >> Share

  24. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    >> Share

  25. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    >> Share

  26. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    >> Share

  27. DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
    Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
    >> Share

  28. COSTA R, Bueno F, Gimenez E, Bracho A, et al
    Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
    >> Share

  29. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    >> Share

  30. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    >> Share

  31. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    >> Share

  32. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    >> Share

    J Infect Dis

  33. TSANG TK, Wu P, Lau EHY, Cowling BJ, et al
    Accounting for Imported Cases in Estimating the Time-Varying Reproductive Number of Coronavirus Disease 2019 in Hong Kong.
    J Infect Dis. 2021;224:783-787.
    >> Share

  34. RAZANI N, Malekinejad M, Rutherford GW
    Clarification Regarding "Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review".
    J Infect Dis. 2021;224:925-926.
    >> Share

  35. RATCLIFF J, Nguyen D, Fish M, Rynne J, et al
    Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.
    J Infect Dis. 2021;224:595-605.
    >> Share

  36. YAO L, Wang GL, Shen Y, Wang ZY, et al
    Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
    J Infect Dis. 2021;224:586-594.
    >> Share

  37. BARTSCH SM, Wedlock PT, O'Shea KJ, Cox SN, et al
    Lives and Costs Saved by Expanding and Expediting COVID-19 Vaccination.
    J Infect Dis. 2021 May 6. pii: 6267841. doi: 10.1093.
    >> Share

  38. RYU S, Hwang Y, Ali ST, Kim DS, et al
    Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.
    J Infect Dis. 2021;224:949-955.
    >> Share

  39. KILLERBY ME, Ata Ur Rasheed M, Tamin A, Harcourt JL, et al
    Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.
    J Infect Dis. 2021;224:771-776.
    >> Share

  40. GRZELAK L, Velay A, Madec Y, Gallais F, et al
    Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;224:983-988.
    >> Share

  41. PICHLER D, Baumgartner M, Kimpel J, Rossler A, et al
    Marked Increase in Avidity of SARS-CoV-2 Antibodies 7-8 Months After Infection Is Not Diminished in Old Age.
    J Infect Dis. 2021;224:764-770.
    >> Share

  42. PEREZ-LAGO L, Martinez-Lozano H, Pajares Diaz JA, Diaz Gomez A, et al
    Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
    J Infect Dis. 2021;224:788-792.
    >> Share

  43. BECKER T, Elbahesh H, Reperant LA, Rimmelzwaan GF, et al
    Influenza Vaccines: Successes and Continuing Challenges.
    J Infect Dis. 2021;224.
    >> Share

  44. FERREIRA IATM, Kemp SA, Datir R, Saito A, et al
    SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
    J Infect Dis. 2021;224:989-994.
    >> Share

  45. ABDELNABI R, Foo CS, De Jonghe S, Maes P, et al
    Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.
    J Infect Dis. 2021;224:749-753.
    >> Share

  46. SMITH RL, Gibson LL, Martinez PP, Ke R, et al
    Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.
    J Infect Dis. 2021;224:976-982.
    >> Share

  47. KOECKERLING D, Barker J
    Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;224:934-937.
    >> Share

  48. CHO K, Keithly SC, Kurgansky KE, Madenci AL, et al
    Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.
    J Infect Dis. 2021;224:967-975.
    >> Share

  49. MA Y, Liu F, Lin T, Chen L, et al
    Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19.
    J Infect Dis. 2021 Jun 18. pii: 6305142. doi: 10.1093.
    >> Share

  50. DEMONBREUN AR, Sancilio A, Velez ME, Ryan DT, et al
    COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.
    J Infect Dis. 2021 Jun 12. pii: 6297423. doi: 10.1093.
    >> Share

    J Virol

  51. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

    J Virol Methods

  52. KIM TY, Kim JY, Shim HJ, Yun SA, et al
    Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus.
    J Virol Methods. 2021 Sep 27:114304. doi: 10.1016/j.jviromet.2021.114304.
    >> Share


  53. SIMON P, Ho A, Shah MD, Shetgiri R, et al
    Trends in Mortality From COVID-19 and Other Leading Causes of Death Among Latino vs White Individuals in Los Angeles County, 2011-2020.
    JAMA. 2021 Jul 19. pii: 2782334. doi: 10.1001/jama.2021.11945.
    >> Share

  54. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    >> Share

  55. KADRI SS, Simpson SQ
    Potential Implications of SARS-CoV-2 Delta Variant Surges for Rural Areas and Hospitals.
    JAMA. 2021 Aug 12. pii: 2783233. doi: 10.1001/jama.2021.13941.
    >> Share

  56. CONGRAVE-WILSON Z, Lee Y, Jumarang J, Perez S, et al
    Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
    JAMA. 2021 Aug 13. pii: 2783249. doi: 10.1001/jama.2021.13967.
    >> Share

  57. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    >> Share

  58. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    >> Share

  59. ABBASI J
    Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
    JAMA. 2021;326:901.
    >> Share

  60. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    >> Share

    It Is What It Is.
    JAMA. 2021;326:1007-1008.
    >> Share

    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.
    >> Share


  63. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share

  64. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    >> Share

  65. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    >> Share

    MMWR Morb Mortal Wkly Rep

  66. RAY LC, Collins JP, Griffin PM, Shah HJ, et al
    Decreased Incidence of Infections Caused by Pathogens Transmitted Commonly Through Food During the COVID-19 Pandemic - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2017-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1332-1336.
    >> Share

  67. SELF WH, Tenforde MW, Rhoads JP, Gaglani M, et al
    Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1337-1343.
    >> Share

  68. DOOLING K, Gargano JW, Moulia D, Wallace M, et al
    Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged >/=16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1344-1348.
    >> Share

  69. HAGAN LM, McCormick DW, Lee C, Sleweon S, et al
    Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1349-1354.
    >> Share

  70. RYERSON AB, Rice CE, Hung MC, Patel SA, et al
    Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status - National Immunization Survey Adult COVID Module, United States, May 30-June 26, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1365-1371.
    >> Share

  71. PARKS SE, Zviedrite N, Budzyn SE, Panaggio MJ, et al
    COVID-19-Related School Closures and Learning Modality Changes - United States, August 1-September 17, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1374-1376.
    >> Share

  72. BUDZYN SE, Panaggio MJ, Parks SE, Papazian M, et al
    Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements - United States, July 1-September 4, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1377-1378.
    >> Share

  73. JEHN M, McCullough JM, Dale AP, Gue M, et al
    Association Between K-12 School Mask Policies and School-Associated COVID-19 Outbreaks - Maricopa and Pima Counties, Arizona, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1372-1373.
    >> Share

  74. HAUSE AM, Baggs J, Gee J, Marquez P, et al
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1379-1384.
    >> Share

    N Engl J Med

  75. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    >> Share

  76. NORTH CS, Sorg EM, Youn S, Chu JT, et al
    Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.
    N Engl J Med. 2021;385:1125-1132.
    >> Share

  77. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    N Engl J Med. 2021;385:e48.
    >> Share


  78. KELLY EH, Rivera F, Tait VF, Hingle ST, et al
    Introduction: Women in Medicine.
    Pediatrics. 2021;148.
    >> Share

    PLoS Comput Biol

  79. GOZZI N, Bajardi P, Perra N
    The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout.
    PLoS Comput Biol. 2021;17:e1009346.
    >> Share

  80. CHIU WA, Ndeffo-Mbah ML
    Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States.
    PLoS Comput Biol. 2021;17:e1009374.
    >> Share

  81. YIN R, Guest JD, Taherzadeh G, Gowthaman R, et al
    Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
    PLoS Comput Biol. 2021;17:e1009380.
    >> Share

  82. ZHANG S, Ponce J, Zhang Z, Lin G, et al
    An integrated framework for building trustworthy data-driven epidemiological models: Application to the COVID-19 outbreak in New York City.
    PLoS Comput Biol. 2021;17:e1009334.
    >> Share

    PLoS One

  83. MYERSON J, Strube MJ, Green L, Hale S, et al
    Individual differences in COVID-19 mitigation behaviors: The roles of age, gender, psychological state, and financial status.
    PLoS One. 2021;16:e0257658.
    >> Share

  84. ARES-BLANCO S, Perez Alvarez M, Gefaell Larrondo I, Munoz C, et al
    SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city.
    PLoS One. 2021;16:e0257604.
    >> Share

  85. GLOGOWSKY U, Hansen E, Schachtele S
    How effective are social distancing policies? Evidence on the fight against COVID-19.
    PLoS One. 2021;16:e0257363.
    >> Share

  86. VILLENA-TEJADA M, Vera-Ferchau I, Cardona-Rivero A, Zamalloa-Cornejo R, et al
    Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey.
    PLoS One. 2021;16:e0257165.
    >> Share

  87. WOOD SN, Wit EC
    Was R < 1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19.
    PLoS One. 2021;16:e0257455.
    >> Share

  88. TAKEUCHI M, Higa Y, Esaki A, Nabeshima Y, et al
    Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
    PLoS One. 2021;16:e0257668.
    >> Share

  89. ALVAREZ-ESTEBAN PC, Del Barrio E, Rueda OM, Rueda C, et al
    Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y Leon (Spain).
    PLoS One. 2021;16:e0257613.
    >> Share

  90. LAREBO YM, Abame DE
    Knowledge, attitudes, and practices of face mask utilization and associated factors in COVID-19 pandemic among Wachemo University Students, Southern Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0257609.
    >> Share

  91. STOEHR F, Muller L, Brady A, Trilla A, et al
    How COVID-19 kick-started online learning in medical education-The DigiMed study.
    PLoS One. 2021;16:e0257394.
    >> Share

  92. ABRAMOVICH A, Pang N, Moss A, Logie CH, et al
    Investigating the impacts of COVID-19 among LGBTQ2S youth experiencing homelessness.
    PLoS One. 2021;16:e0257693.
    >> Share

  93. OGOINA D, Mahmood D, Oyeyemi AS, Okoye OC, et al
    A national survey of hospital readiness during the COVID-19 pandemic in Nigeria.
    PLoS One. 2021;16:e0257567.
    >> Share

  94. ROY N, Amin MB, Maliha MJ, Sarker B, et al
    Prevalence and factors associated with family planning during COVID-19 pandemic in Bangladesh: A cross-sectional study.
    PLoS One. 2021;16:e0257634.
    >> Share

  95. FUKUDA Y, Ando S, Fukuda K
    Knowledge and preventive actions toward COVID-19, vaccination intent, and health literacy among educators in Japan: An online survey.
    PLoS One. 2021;16:e0257552.
    >> Share

    Network assessment and modeling the management of an epidemic on a college campus with testing, contact tracing, and masking.
    PLoS One. 2021;16:e0257052.
    >> Share

  97. TCHICAYA A, Lorentz N, Leduc K, de Lanchy G, et al
    COVID-19 mortality with regard to healthcare services availability, health risks, and socio-spatial factors at department level in France: A spatial cross-sectional analysis.
    PLoS One. 2021;16:e0256857.
    >> Share

  98. HEWAMANA S, Skandarajah T, Jayasinghe C, Deshapriya S, et al
    Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka.
    PLoS One. 2021;16:e0256941.
    >> Share

  99. EDGE R, Meyers J, Tiernan G, Li Z, et al
    Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective.
    PLoS One. 2021;16:e0257420.
    >> Share

  100. GUEDES MBOG, de Assis SJC, Sanchis GJB, Araujo DN, et al
    COVID-19 in Brazilian cities: Impact of social determinants, coverage and quality of primary health care.
    PLoS One. 2021;16:e0257347.
    >> Share

  101. WU H, Wu C, Lu Q, Ding Z, et al
    Spatiotemporal analysis and the characteristics of the case transmission network of 2019 novel coronavirus disease (COVID-19) in Zhejiang Province, China.
    PLoS One. 2021;16:e0257587.
    >> Share

  102. NUERTEY BD, Ekremet K, Haidallah AR, Mumuni K, et al
    Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection.
    PLoS One. 2021;16:e0257450.
    >> Share

  103. TATEYAMA-MAKINO R, Abe-Yutori M, Iwamoto T, Tsutsumi K, et al
    The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2 in vitro.
    PLoS One. 2021;16:e0257705.
    >> Share

  104. TOLCHIN B, Oladele C, Galusha D, Kashyap N, et al
    Racial disparities in the SOFA score among patients hospitalized with COVID-19.
    PLoS One. 2021;16:e0257608.
    >> Share

  105. GLENNON K, Donnelly J, Knowles S, McAuliffe FM, et al
    Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study.
    PLoS One. 2021;16:e0253090.
    >> Share

  106. MARQUEZ C, Kerkhoff AD, Naso J, Contreras MG, et al
    A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice.
    PLoS One. 2021;16:e0257111.
    >> Share

  107. SHIMIZUTANI S, Yamada E
    Resilience against the pandemic: The impact of COVID-19 on migration and household welfare in Tajikistan.
    PLoS One. 2021;16:e0257469.
    >> Share

  108. QUIROZ-JUAREZ MA, Torres-Gomez A, Hoyo-Ulloa I, Leon-Montiel RJ, et al
    Identification of high-risk COVID-19 patients using machine learning.
    PLoS One. 2021;16:e0257234.
    >> Share

  109. GOMEZ-SALGADO J, Adanaque-Bravo I, Ortega-Moreno M, Allande-Cusso R, et al
    Psychological distress during the first phase of the COVID-19 pandemic in Ecuador: Cross-sectional study.
    PLoS One. 2021;16:e0257661.
    >> Share

  110. OMRAN D, Al Soda M, Bahbah E, Esmat G, et al
    Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter study.
    PLoS One. 2021;16:e0256203.
    >> Share

  111. YIN Y, Shi F, Zhang Y, Zhang X, et al
    Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement.
    PLoS One. 2021;16:e0257093.
    >> Share

  112. JONES L, Bakre A, Naikare H, Kolhe R, et al
    Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
    PLoS One. 2021;16:e0257563.
    >> Share

  113. CHENG HM, Zhao X, Lim WS, Tan BJM, et al
    Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility.
    PLoS One. 2021;16:e0257565.
    >> Share

  114. SCHRORS B, Riesgo-Ferreiro P, Sorn P, Gudimella R, et al
    Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.
    PLoS One. 2021;16:e0249254.
    >> Share

  115. HALFON P, Penaranda G, Khiri H, Garcia V, et al
    An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients.
    PLoS One. 2021;16:e0257817.
    >> Share

  116. RUNDE BJ
    Time to publish? Turnaround times, acceptance rates, and impact factors of journals in fisheries science.
    PLoS One. 2021;16:e0257841.
    >> Share

  117. RADTKE T, Haile SR, Dressel H, Benden C, et al
    COVID-19 pandemic restrictions continuously impact on physical activity in adults with cystic fibrosis.
    PLoS One. 2021;16:e0257852.
    >> Share

  118. SUTANDYO N, Kurniawati SA, Jayusman AM, Syafiyah AH, et al
    Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19.
    PLoS One. 2021;16:e0257775.
    >> Share

  119. COMAN C, Mesesan-Schmitz L, Tiru LG, Grosseck G, et al
    Dear student, what should I write on my wall? A case study on academic uses of Facebook and Instagram during the pandemic.
    PLoS One. 2021;16:e0257729.
    >> Share

  120. JAKUBOWSKI TD, Sitko-Dominik MM
    Teachers' mental health during the first two waves of the COVID-19 pandemic in Poland.
    PLoS One. 2021;16:e0257252.
    >> Share

  121. HOPFER S, Fields EJ, Lu Y, Ramakrishnan G, et al
    The social amplification and attenuation of COVID-19 risk perception shaping mask wearing behavior: A longitudinal twitter analysis.
    PLoS One. 2021;16:e0257428.
    >> Share

  122. CARVALHO RF, Oliveira MDS, Ribeiro J, Dos Santos IGC, et al
    Validation of conventional PCR-like alternative to SARS-CoV-2 detection with target nucleocapsid protein gene in naso-oropharyngeal samples.
    PLoS One. 2021;16:e0257350.
    >> Share

  123. TRUJILLO M, Cheung K, Gao A, Hoxie I, et al
    Protocol for safe, affordable, and reproducible isolation and quantitation of SARS-CoV-2 RNA from wastewater.
    PLoS One. 2021;16:e0257454.
    >> Share

  124. SAEED S, O'Brien SF, Abe K, Yi QL, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
    PLoS One. 2021;16:e0257743.
    >> Share

    Proc Natl Acad Sci U S A

  125. ANDERSON DE, Cui J, Ye Q, Huang B, et al
    Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  126. CRONIN CJ, Evans WN
    Excess mortality from COVID and non-COVID causes in minority populations.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  127. DUCH R, Roope LSJ, Violato M, Fuentes Becerra M, et al
    Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  128. JIN W, Stokes JM, Eastman RT, Itkin Z, et al
    Deep learning identifies synergistic drug combinations for treating COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  129. MCGEE RS, Homburger JR, Williams HE, Bergstrom CT, et al
    Model-driven mitigation measures for reopening schools during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  130. LOURDA M, Dzidic M, Hertwig L, Bergsten H, et al
    High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  131. VELU C, Iyer S
    Learning from near misses from COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


  132. WAINSTOCK T, Yoles I, Sergienko R, Sheiner E, et al
    Prenatal maternal COVID-19 vaccination and pregnancy outcomes.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01191.
    >> Share

  133. PALLIKKUTH S, Williams E, Pahwa R, Hoffer M, et al
    Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers.
    Vaccine. 2021;39:6019-6024.
    >> Share

  134. ZHOU Z, Zhang X, Li Q, Fu L, et al
    Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19.
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)01165.
    >> Share

  135. XU X, Rodgers MD, Guo WG
    A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01117.
    >> Share

  136. ALBANI VVL, Loria J, Massad E, Zubelli JP, et al
    The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York City.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01158.
    >> Share

  137. RIZK JG, Barr CE, Rizk Y, Lewin JC, et al
    The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action.
    Vaccine. 2021 Aug 10. pii: S0264-410X(21)01006.
    >> Share

  138. ALI A, Dwyer D, Wu Q, Wang Q, et al
    Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01126.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016